
Please try another search
On Wednesday, Axis Capital (NYSE:AXS) Limited revised the price target for Zydus Lifesciences (ZYDUSLIF:IN), decreasing it to INR 1,160 from INR 1,180 while keeping a Reduce rating on the stock....
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review